Richard Laing, MBChB, MSc (CHDC) MD
Boston University School of Public Health
Dept of Global Health

MBChB, University of Zimbabwe
MD, University of Zimbabwe
MSc, University of London

2009 Utrecht University: Honorary degree Doctoris Honoris Causae
1985-1986 Beit Trust: Beit Fellowship
1984-1985 Commonwealth Secretariat: Commonwealth Fellowship

04/01/2017 - 03/31/2019 (PI)
International Federation of Pharmaceutical Manufacturers Association

Novartis Access Initiative Task Order 3
10/01/2016 - 12/31/2017 (PI)
Sandoz International GmbH

08/01/2016 - 08/31/2017 (PI)
International Federation of Pharmaceutical Manufacturers Association

Novartis Access Initiative Task Order 2
04/29/2016 - 04/30/2017 (PI)
Sandoz International GmbH

Novartis Access Initiative Task Order 1
12/01/2015 - 04/30/2017 (PI)
Sandoz International GmbH

Yr Title Project-Sub Proj Pubs
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Rockers PC, Wirtz VJ, Umeh CA, Swamy PM, Laing RO. Industry-Led Access-To-Medicines Initiatives In Low- And Middle-Income Countries: Strategies And Evidence. Health Aff (Millwood). 2017 Apr 01; 36(4):706-713.View Related Profiles. PMID: 28373337; DOI: 10.1377/hlthaff.2016.1213;.
  2. Ewen M, Zweekhorst M, Regeer B, Laing R. Baseline assessment of WHO''s target for both availability and affordability of essential medicines to treat non-communicable diseases. PLoS One. 2017; 12(2):e0171284. PMID: 28170413; DOI: 10.1371/journal.pone.0171284;.
  3. Rockers PC, Wirtz VJ, Vian T, Onyango MA, Ashigbie PG, Laing R. Study protocol for a cluster-randomised controlled trial of an NCD access to medicines initiative: evaluation of Novartis Access in Kenya. BMJ Open. 2016 Nov 25; 6(11):e013386.View Related Profiles. PMID: 27888177; DOI: 10.1136/bmjopen-2016-013386;.
  4. Wirtz VJ, Kaplan WA, Kwan GF, Laing RO. Response by Wirtz et al to Letter Regarding Article, "Access to Medications for Cardiovascular Diseases in Low- and Middle-Income Countries". Circulation. 2016 Oct 04; 134(14):e305-e306.View Related Profiles. PMID: 27698055.
  5. Beran D, Ewen M, Laing R. Insulin in 2016: Challenge and constraints to access. Diabetes Res Clin Pract. 2016 Jul; 117:119-21. PMID: 27329030; DOI: 10.1016/j.diabres.2016.06.001;.
  6. Wirtz VJ, Kaplan WA, Kwan GF, Laing RO. Access to Medications for Cardiovascular Diseases in Low- and Middle-Income Countries. Circulation. 2016 May 24; 133(21):2076-85.View Related Profiles. PMID: 27217433; PMCID: PMC4880457; DOI: 10.1161/CIRCULATIONAHA.115.008722;.
  7. Sharma A, Rorden L, Ewen M, Laing R. Evaluating availability and price of essential medicines in Boston area (Massachusetts, USA) using WHO/HAI methodology. J Pharm Policy Pract. 2016; 9:12. PMID: 27054040; DOI: 10.1186/s40545-016-0059-5;.
  8. Beran D, Ewen M, Laing R. Constraints and challenges in access to insulin: a global perspective. Lancet Diabetes Endocrinol. 2016 Mar; 4(3):275-85. PMID: 26857998; DOI: 10.1016/S2213-8587(15)00521-5;.
  9. Kaplan W, Laing R, Ewen M, Beran D. Insulin patents and market exclusivities: unresolved issues. Lancet Diabetes Endocrinol. 2016 Feb; 4(2):98.View Related Profiles. PMID: 26825233; DOI: 10.1016/S2213-8587(15)00496-9;.
  10. Hazel Bradley, Siraaj Adams, Ricardo Kettledas, Tania Mathys, Margaret von Zeil, Richard Laing. Innovations to improve access to and use of medicines for chronic conditions. South African Pharmacy Journal. 2016; 83(5):36-40.
Showing 10 of 47 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 46 publications over 15 distinct years, with a maximum of 8 publications in 2016

Contact for Mentoring:

801 Massachusetts Ave Crosstown Center
Boston MA 02118
Google Map

Laing's Networks
Click the "See All" links for more information and interactive visualizations
Similar People
Same Department